Literature DB >> 12701826

Acute and moderate-term creatine monohydrate supplementation does not affect creatine transporter mRNA or protein content in either young or elderly humans.

Mark Tarnopolsky1, Gianni Parise, Min-Hua Fu, Andrea Brose, Andrew Parshad, Oliver Speer, Theo Wallimann.   

Abstract

Animal studies have shown that supra-physiological creatine monohydrate (Cr-mH) supplementation for 3 months reduced skeletal muscle creatine transporter (CRT) content. The doses of Cr-mH (1-2 g/kg/day) used in these studies were between 5 and 10 times those usually used in human studies, and it is unclear whether a down-regulation of CRT would occur in humans at the recommended doses of 0.1-0.2 g/kg/day. We measured CRT, and citrate synthase (CS) protein content using Western blotting before and after 2 months of Cr-mH supplementation and weight training in young men (N = 11 Cr-mH (0.125 g/kg/ day); N = 8 placebo). CRT and CS were also measured before and after 4 months of Cr-mH supplementation and weight training in elderly (> 65 years) men and women (N = 14 Cr-mH (0.075 g/kg/day); N = 14 placebo). Finally, CRT mRNA was measured using competitive RT-PCR before and after 8-9 days of Cr-mH loading in young men and women (N = 14, CR-mH (mean = 0.18 g/kg/day); N = 13, PL). Total creatine content was significantly elevated after the Cr-mH supplementation period as compared to placebo in each of the studies. Neither Cr-mH supplementation, nor exercise training resulted in measurable alterations in CRT protein content and acute Cr-mH loading did not alter CRT mRNA. There were no gender differences in CRT mRNA or total creatine content in the young subjects and no gender differences in total creatine content or CRT protein content in the elderly subjects. Weight training in young men did not increase CS protein content, however, in the elderly there was a significant increase in CS protein content after exercise training (p < 0.05). These results demonstrated that Cr-mH supplementation during weight training resulted in increases in skeletal muscle total creatine without reductions in CRT protein and acute Cr-mH loading did not decrease CRT mRNA content.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12701826

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

1.  Creatine transporter protein content, localization, and gene expression in rat skeletal muscle.

Authors:  R Murphy; G McConell; D Cameron-Smith; K Watt; L Ackland; B Walzel; T Wallimann; R Snow
Journal:  Am J Physiol Cell Physiol       Date:  2001-03       Impact factor: 4.249

2.  Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease.

Authors:  M A Tarnopolsky; G Parise
Journal:  Muscle Nerve       Date:  1999-09       Impact factor: 3.217

3.  Identification of a testis-expressed creatine transporter gene at 16p11.2 and confirmation of the X-linked locus to Xq28.

Authors:  G S Iyer; R Krahe; L A Goodwin; N A Doggett; M J Siciliano; V L Funanage; R Proujansky
Journal:  Genomics       Date:  1996-05-15       Impact factor: 5.736

4.  Long-term creatine intake is beneficial to muscle performance during resistance training.

Authors:  K Vandenberghe; M Goris; P Van Hecke; M Van Leemputte; L Vangerven; P Hespel
Journal:  J Appl Physiol (1985)       Date:  1997-12

5.  Extracellular creatine regulates creatine transport in rat and human muscle cells.

Authors:  J D Loike; D L Zalutsky; E Kaback; A F Miranda; S C Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

6.  Creatine transporter and mitochondrial creatine kinase protein content in myopathies.

Authors:  M A Tarnopolsky; A Parshad; B Walzel; U Schlattner; T Wallimann
Journal:  Muscle Nerve       Date:  2001-05       Impact factor: 3.217

7.  Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training.

Authors:  J S Volek; N D Duncan; S A Mazzetti; R S Staron; M Putukian; A L Gómez; D R Pearson; W J Fink; W J Kraemer
Journal:  Med Sci Sports Exerc       Date:  1999-08       Impact factor: 5.411

8.  Creatine metabolism in skeletal muscle. I. Creatine movement across muscle membranes.

Authors:  C D Fitch; R P Shields
Journal:  J Biol Chem       Date:  1966-08-10       Impact factor: 5.157

9.  Guanidinoacetate methyltransferase deficiency: a newly recognized inborn error of creatine biosynthesis.

Authors:  S Stöckler; F Hanefeld
Journal:  Wien Klin Wochenschr       Date:  1997-02-14       Impact factor: 1.704

10.  New creatine transporter assay and identification of distinct creatine transporter isoforms in muscle.

Authors:  Bernd Walzel; Oliver Speer; Ernie Boehm; Søren Kristiansen; Sharon Chan; Kierian Clarke; Joseph P Magyar; Erik A Richter; Theo Wallimann
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-08       Impact factor: 4.310

View more
  12 in total

Review 1.  X-linked creatine transporter deficiency: clinical aspects and pathophysiology.

Authors:  Jiddeke M van de Kamp; Grazia M Mancini; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

2.  Effects of N-linked glycosylation on the creatine transporter.

Authors:  Nadine Straumann; Alexandra Wind; Tina Leuenberger; Theo Wallimann
Journal:  Biochem J       Date:  2006-01-15       Impact factor: 3.857

Review 3.  Training-induced changes in membrane transport proteins of human skeletal muscle.

Authors:  Carsten Juel
Journal:  Eur J Appl Physiol       Date:  2006-02-03       Impact factor: 3.078

Review 4.  The role of creatine in the management of amyotrophic lateral sclerosis and other neurodegenerative disorders.

Authors:  Amy Cameron Ellis; Jeffrey Rosenfeld
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 5.  Bioavailability, Efficacy, Safety, and Regulatory Status of Creatine and Related Compounds: A Critical Review.

Authors:  Richard B Kreider; Ralf Jäger; Martin Purpura
Journal:  Nutrients       Date:  2022-02-28       Impact factor: 5.717

6.  Interactions of aging, overload, and creatine supplementation in rat plantaris muscle.

Authors:  Mark D Schuenke; Naomi E Brooks; Robert S Hikida
Journal:  J Aging Res       Date:  2011-08-11

Review 7.  Novel insights on nutrient management of sarcopenia in elderly.

Authors:  Mariangela Rondanelli; Milena Faliva; Francesca Monteferrario; Gabriella Peroni; Erica Repaci; Francesca Allieri; Simone Perna
Journal:  Biomed Res Int       Date:  2015-01-29       Impact factor: 3.411

Review 8.  Variables Influencing the Effectiveness of Creatine Supplementation as a Therapeutic Intervention for Sarcopenia.

Authors:  Darren G Candow; Scott C Forbes; Philip D Chilibeck; Stephen M Cornish; Jose Antonio; Richard B Kreider
Journal:  Front Nutr       Date:  2019-08-09

9.  The regulation and expression of the creatine transporter: a brief review of creatine supplementation in humans and animals.

Authors:  Ryan D Schoch; Darryn Willoughby; Mike Greenwood
Journal:  J Int Soc Sports Nutr       Date:  2006-06-23       Impact factor: 5.150

Review 10.  Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy.

Authors:  Emma Rybalka; Cara A Timpani; Christos G Stathis; Alan Hayes; Matthew B Cooke
Journal:  Nutrients       Date:  2015-11-26       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.